Analyst firms · Wells Fargo · EXAS

Wells Fargo EXAS price target and rating history

Exact Sciences Corporation (EXAS) · Health Care

Wells Fargo rates Exact Sciences Corporation (EXAS) Overweight with a $75 price target, as of its latest action on Aug 28, 2024. It has published 3 rating actions on EXAS since November 2021, including 0 upgrades and 0 downgrades.

Current rating
Overweight
Price target
$75
Median target, all firms
Too few
Actions on EXAS
3

Wells Fargo price target on EXAS

$95$85$7520222023202420252026
Wells Fargo price target on EXAS, each point a stated target, November 2021 to August 2024.

Every Wells Fargo rating on EXAS

How other firms rate EXAS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
MizuhoNeutral$105Jan 20, 2026
Evercore ISIIn-line$105Jan 5, 2026

Questions about Wells Fargo and EXAS

What is Wells Fargo's price target for EXAS?
Wells Fargo's latest stated price target for Exact Sciences Corporation (EXAS) is $75, from its action on Aug 28, 2024.
What is Wells Fargo's rating on EXAS?
Wells Fargo rates EXAS Overweight, a bullish rating, as of Aug 28, 2024.
When did Wells Fargo last change its view on EXAS?
On Aug 28, 2024, Wells Fargo starts coverage at Overweight, price target $75.

More EXAS rating histories

All Wells Fargo ratingsEXAS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.